Jordan Dawsey
Internal Medicine · Aiken, SCNPI 1992419170
Payments from drug & device makers
Across 99 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$391
- AbbVie$294
- Lilly USA, LLC$275
- Novo Nordisk$121
- Daiichi Sankyo Inc.$83
- Boston Scientific$83
- plus $676 from 23 others
What the payments were for
- Food & beverage$1,923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $391 |
| AbbVie | 23 | $294 |
| Lilly USA, LLC | 12 | $275 |
| Novo Nordisk | 5 | $121 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Boston Scientific | 4 | $83 |
| Boehringer Ingelheim | 3 | $72 |
| Exact Sciences | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 3 | $51 |
| GSK | 3 | $48 |
| Novartis | 2 | $39 |
| Pfizer | 2 | $37 |
| Edwards Lifesciences | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Stryker | 1 | $29 |
| Amgen | 1 | $26 |
| Pulmonx Corporation | 1 | $26 |
| Cvrx, Inc. | 2 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Abiomed | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Inari Medical, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,923 in reported general payments places this provider in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $59,591 |
| FarxigaDapagliflozin Propanediol | 46 | $52,861 |
| JardianceEmpagliflozin | 36 | $37,993 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $25,236 |
| TrulicityDulaglutide | 20 | $23,628 |
| MounjaroTirzepatide | 14 | $16,122 |
| EliquisApixaban | 20 | $13,105 |
| BrilintaTicagrelor | 12 | $5,093 |
| Gabapentin | 85 | $2,012 |
| Levothyroxine Sodium | 133 | $1,926 |
| Atorvastatin Calcium | 141 | $1,802 |
| Losartan Potassium | 110 | $1,678 |
| SynthroidLevothyroxine Sodium | 12 | $1,469 |
| Pantoprazole Sodium | 99 | $1,397 |
| Sucralfate | 15 | $1,161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $121 | $59,59152 claims |
| AstraZenecaFarxiga, Brilinta | $391 | $57,95558 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $275 | $40,34146 claims |
| Boehringer IngelheimJardiance | $72 | $37,99336 claims |
| GSKTrelegy Ellipta | $48 | $25,23621 claims |
| PfizerEliquis | $37 | $13,10520 claims |
| AbbVieSynthroid | $294 | $1,46912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Aiken
- Gerald GordonAiken$13K
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.